Each year I’m honored to attend ASH with the IMF. I’ve been a myeloma survivor for 16 years and am encouraged to continue to share all the good news from ASH. When I first attended ASH with the IMF about 10 years ago, there were not nearly as many trials as we have now. It […]
ASH 2016: Patient Perspective with Michael Tuohy
Sixteen-year myeloma survivor Michael Tuohy expresses his gratitude to the IMF for making him part of the team of Support Group Leaders who attended the 58th American Society of Hematology annual meeting.
Researchers and patients mingle together
Saturday: Day 2 at #ASH16 started with an early morning breakfast meeting with the International Myeloma Working Group (IMWG). The room was packed with myeloma experts from all over the world, welcoming in 17 new members, reviewing 2016 papers and most importantly deciding on the topics of their next projects. I was happy to see […]
The excitement builds!
Each year, ASH comes on the heels of Thanksgiving, which is one of my favorite holidays. It’s the perfect opportunity to reflect on all there is to be thankful for, including all the research being done in our myeloma world. When I was diagnosed with myeloma in 2000, the options were few and side effects […]
Michael Tuohy
Michael Tuohy is a sixteen-year multiple myeloma survivor, having been diagnosed in 2000 at the age of 36. He had an autologous stem cell transplant in 2002, and is currently on Revlimid® (11 years.) He and his wife Robin started the first myeloma support group in Connecticut in the spring of 2001 with the help of the IMF, which is known as the Connecticut Multiple Myeloma Fighters Information Group.
Follow Michael on Twitter